ArticleBlood2012

Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice.

Camila Bononi Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.